We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Clinical Trial Exposes Kidney Cancer's Weakness

News   Feb 21, 2020 | Original story from UT Southwestern Medical Center

 
Clinical Trial Exposes Kidney Cancer's Weakness
 
 
Advertisement
 

RELATED ARTICLES

Antiviral Against COVID-19 Reduces Damage in Mouse Lungs

News

Scientists are optimistic that a new compound, dubbed EIDD-2801, could be effective in treating the symptoms of COVID-19. The candidate drug has shown efficacy in reducing lung damage in mouse studies, and will soon progress to clinical trials in humans.

READ MORE

Nanovesicle Delivery Could Help Treat Brain Cancers and Neurological Diseases

News

A targeted therapy currently being studied for treatment of certain cancers including glioblastoma, could also be used to treat other neurologic diseases, according to new research.

READ MORE

Genetic System Can Reduce COVID-19 Vaccine Development Timeframe

News

A multidisciplinary team at The University of Texas Medical Branch at Galveston working to combat the COVID-19 virus has a system that will unlock researchers’ ability to more quickly develop and evaluate developing vaccines, diagnose infected patients and explore whether or how the virus has evolved.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE